mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
8e-05 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
8e-05 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |